2m 2m 2m 2m 2m 2m 2m
Faeth Therapeuti (FTH)
NASDAQ
$20.09-$0.48 (-2.33%)
Price as of Oct 22, 2026 4:25 PM EDT- $531.5MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
Faeth Therapeuti (FTH)
$20.09-$0.48 (-2.33%)
FTH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.57 | ||
Change | -$0.22 (-1.06%) | ||
Open | $20.84 | ||
High | $21.97 | ||
Low | $20.32 | ||
Previous Close | $20.79 | ||
Volume | 182,417 | ||
30-Day Average Volume | 367,813 | ||
1-Week Change | 2.85% | ||
1-Month Change | -38.21% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 25.8M | ||
Total Assets | $189.3M | ||
Market Cap | $531.5M | ||
Enterprise Value | $504.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$16.0M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$16.0M | ||
EBITDA | -$16.0M | ||
Net Working Capital | $179.1M | ||
EPS | -$2.84 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue